Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Rheumatoid | 87 | 2024 | 3778 | 7.660 |
Why?
|
Quantitative Trait Loci | 26 | 2024 | 2131 | 4.870 |
Why?
|
HLA Antigens | 16 | 2024 | 1334 | 3.530 |
Why?
|
Genome-Wide Association Study | 107 | 2024 | 12790 | 3.480 |
Why?
|
Polymorphism, Single Nucleotide | 113 | 2024 | 16036 | 3.420 |
Why?
|
Genetic Predisposition to Disease | 118 | 2024 | 18063 | 3.380 |
Why?
|
Synovial Membrane | 14 | 2024 | 536 | 3.180 |
Why?
|
Psoriasis | 20 | 2024 | 925 | 2.490 |
Why?
|
Autoimmune Diseases | 14 | 2024 | 2255 | 2.480 |
Why?
|
Single-Cell Analysis | 19 | 2024 | 2538 | 2.090 |
Why?
|
Alleles | 57 | 2024 | 6893 | 2.050 |
Why?
|
Genetic Variation | 34 | 2024 | 6611 | 1.950 |
Why?
|
Linkage Disequilibrium | 22 | 2021 | 1996 | 1.850 |
Why?
|
Rheumatic Diseases | 6 | 2021 | 659 | 1.800 |
Why?
|
Chromosome Mapping | 21 | 2024 | 4616 | 1.640 |
Why?
|
Fibroblasts | 15 | 2024 | 4167 | 1.630 |
Why?
|
Genetic Loci | 32 | 2021 | 2629 | 1.470 |
Why?
|
Regulatory Sequences, Nucleic Acid | 4 | 2024 | 792 | 1.370 |
Why?
|
Chromatin | 8 | 2024 | 2980 | 1.360 |
Why?
|
Macular Degeneration | 13 | 2016 | 1015 | 1.350 |
Why?
|
Histocompatibility Antigens Class I | 5 | 2023 | 1362 | 1.310 |
Why?
|
Mycobacterium tuberculosis | 7 | 2024 | 1911 | 1.300 |
Why?
|
Gene Expression Regulation | 22 | 2024 | 11923 | 1.260 |
Why?
|
Genetics, Population | 4 | 2021 | 943 | 1.260 |
Why?
|
Haplotypes | 23 | 2023 | 2722 | 1.260 |
Why?
|
Immunologic Memory | 4 | 2024 | 1377 | 1.240 |
Why?
|
Molecular Sequence Annotation | 7 | 2020 | 526 | 1.230 |
Why?
|
Major Histocompatibility Complex | 7 | 2014 | 879 | 1.230 |
Why?
|
T-Lymphocyte Subsets | 7 | 2023 | 1814 | 1.200 |
Why?
|
Receptors, Antigen, T-Cell | 6 | 2024 | 2568 | 1.160 |
Why?
|
CD4-Positive T-Lymphocytes | 13 | 2024 | 4405 | 1.150 |
Why?
|
Rheumatology | 4 | 2022 | 617 | 1.150 |
Why?
|
Autoimmunity | 7 | 2024 | 1361 | 1.140 |
Why?
|
Host-Pathogen Interactions | 5 | 2024 | 1466 | 1.120 |
Why?
|
HLA-B Antigens | 7 | 2020 | 330 | 1.110 |
Why?
|
Phenotype | 25 | 2024 | 16718 | 1.000 |
Why?
|
Amino Acids | 10 | 2023 | 1712 | 1.000 |
Why?
|
Genome, Human | 19 | 2023 | 4441 | 1.000 |
Why?
|
Disease | 4 | 2016 | 675 | 0.940 |
Why?
|
Genotype | 42 | 2024 | 13035 | 0.910 |
Why?
|
Diabetes Mellitus, Type 1 | 9 | 2021 | 3449 | 0.870 |
Why?
|
Complement Factor H | 7 | 2016 | 110 | 0.860 |
Why?
|
Selection, Genetic | 5 | 2021 | 877 | 0.860 |
Why?
|
Tumor Necrosis Factor-alpha | 12 | 2024 | 4349 | 0.840 |
Why?
|
B-Lymphocytes | 8 | 2024 | 4787 | 0.830 |
Why?
|
Peru | 6 | 2024 | 888 | 0.810 |
Why?
|
T-Lymphocytes | 9 | 2024 | 10254 | 0.800 |
Why?
|
Humans | 260 | 2024 | 767040 | 0.800 |
Why?
|
Physical Chromosome Mapping | 2 | 2021 | 183 | 0.780 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2024 | 812 | 0.780 |
Why?
|
Arthritis, Psoriatic | 4 | 2022 | 219 | 0.770 |
Why?
|
Stromal Cells | 4 | 2022 | 1335 | 0.770 |
Why?
|
Histocompatibility Antigens Class II | 6 | 2023 | 1442 | 0.770 |
Why?
|
Lupus Erythematosus, Systemic | 5 | 2021 | 2160 | 0.770 |
Why?
|
Monocytes | 6 | 2022 | 2598 | 0.760 |
Why?
|
Interleukin-17 | 2 | 2020 | 922 | 0.740 |
Why?
|
Tuberculosis | 3 | 2024 | 2011 | 0.740 |
Why?
|
Software | 9 | 2021 | 4472 | 0.740 |
Why?
|
Gene Frequency | 19 | 2021 | 3621 | 0.730 |
Why?
|
Multifactorial Inheritance | 7 | 2022 | 1422 | 0.720 |
Why?
|
Case-Control Studies | 44 | 2021 | 22254 | 0.720 |
Why?
|
Cytokines | 8 | 2023 | 7446 | 0.720 |
Why?
|
Genetic Pleiotropy | 3 | 2016 | 181 | 0.710 |
Why?
|
Antirheumatic Agents | 11 | 2024 | 1379 | 0.700 |
Why?
|
Genome | 4 | 2023 | 1752 | 0.700 |
Why?
|
Computational Biology | 16 | 2021 | 3567 | 0.700 |
Why?
|
Quantitative Trait, Heritable | 4 | 2021 | 539 | 0.690 |
Why?
|
Genomics | 11 | 2023 | 5924 | 0.690 |
Why?
|
Gene Expression Profiling | 18 | 2024 | 9532 | 0.680 |
Why?
|
Lupus Nephritis | 5 | 2022 | 324 | 0.680 |
Why?
|
Celiac Disease | 7 | 2022 | 821 | 0.650 |
Why?
|
HLA-C Antigens | 3 | 2022 | 146 | 0.650 |
Why?
|
Tuberculosis, Pulmonary | 2 | 2021 | 836 | 0.640 |
Why?
|
HLA-D Antigens | 2 | 2016 | 130 | 0.630 |
Why?
|
Genetic Markers | 3 | 2016 | 2602 | 0.620 |
Why?
|
Complementarity Determining Regions | 3 | 2024 | 154 | 0.600 |
Why?
|
Flow Cytometry | 9 | 2020 | 5891 | 0.590 |
Why?
|
Immune System Diseases | 5 | 2019 | 253 | 0.590 |
Why?
|
Complement Factor I | 2 | 2015 | 14 | 0.570 |
Why?
|
Genes | 5 | 2019 | 1824 | 0.570 |
Why?
|
Mutation, Missense | 5 | 2020 | 2592 | 0.570 |
Why?
|
Meta-Analysis as Topic | 8 | 2016 | 1364 | 0.570 |
Why?
|
Body Height | 3 | 2020 | 1565 | 0.560 |
Why?
|
Repressor Proteins | 4 | 2020 | 2979 | 0.550 |
Why?
|
Keratinocytes | 5 | 2019 | 876 | 0.550 |
Why?
|
Databases, Genetic | 12 | 2021 | 1758 | 0.540 |
Why?
|
Th17 Cells | 2 | 2021 | 790 | 0.540 |
Why?
|
Complement C3 | 2 | 2021 | 434 | 0.540 |
Why?
|
Gene Deletion | 4 | 2013 | 2668 | 0.510 |
Why?
|
Blood Cells | 1 | 2017 | 309 | 0.500 |
Why?
|
Macrophages | 5 | 2024 | 5785 | 0.500 |
Why?
|
Nerve Growth Factor | 3 | 2009 | 156 | 0.500 |
Why?
|
Epigenomics | 2 | 2019 | 959 | 0.490 |
Why?
|
Lymphocyte Activation | 5 | 2024 | 5499 | 0.480 |
Why?
|
Transcription Factors | 6 | 2024 | 12158 | 0.480 |
Why?
|
Arthritis, Experimental | 1 | 2017 | 293 | 0.470 |
Why?
|
Enhancer Elements, Genetic | 2 | 2020 | 1366 | 0.460 |
Why?
|
Receptors, Interleukin-17 | 1 | 2014 | 82 | 0.460 |
Why?
|
Complement C9 | 1 | 2013 | 15 | 0.450 |
Why?
|
Genes, Fungal | 4 | 2003 | 440 | 0.440 |
Why?
|
Amino Acid Substitution | 5 | 2017 | 1743 | 0.440 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2022 | 2902 | 0.420 |
Why?
|
Models, Genetic | 10 | 2021 | 3445 | 0.420 |
Why?
|
Immune System | 2 | 2016 | 799 | 0.420 |
Why?
|
Inflammation | 11 | 2023 | 10869 | 0.410 |
Why?
|
Dermatitis | 3 | 2001 | 203 | 0.410 |
Why?
|
Genetic Heterogeneity | 4 | 2016 | 735 | 0.410 |
Why?
|
Inflammatory Bowel Diseases | 5 | 2024 | 2441 | 0.410 |
Why?
|
Research Design | 4 | 2023 | 6210 | 0.400 |
Why?
|
Blood Proteins | 2 | 2024 | 1190 | 0.400 |
Why?
|
Crohn Disease | 9 | 2024 | 2295 | 0.390 |
Why?
|
Promoter Regions, Genetic | 3 | 2020 | 5796 | 0.390 |
Why?
|
Cluster Analysis | 7 | 2022 | 2721 | 0.390 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1882 | 0.390 |
Why?
|
Natural Killer T-Cells | 2 | 2019 | 319 | 0.380 |
Why?
|
Arthritis | 4 | 2024 | 684 | 0.380 |
Why?
|
Algorithms | 17 | 2021 | 14098 | 0.380 |
Why?
|
Schizophrenia | 9 | 2019 | 6977 | 0.370 |
Why?
|
Immunophenotyping | 5 | 2019 | 1864 | 0.370 |
Why?
|
Calcium Channels, L-Type | 2 | 2014 | 243 | 0.360 |
Why?
|
Complement C3b Inactivator Proteins | 1 | 2010 | 13 | 0.360 |
Why?
|
Gene Expression | 8 | 2020 | 7587 | 0.360 |
Why?
|
Disease Progression | 8 | 2021 | 13646 | 0.360 |
Why?
|
Genetic Association Studies | 10 | 2021 | 2744 | 0.360 |
Why?
|
Homeodomain Proteins | 1 | 2020 | 2429 | 0.350 |
Why?
|
Autoantibodies | 13 | 2020 | 2114 | 0.350 |
Why?
|
Sequence Analysis, RNA | 4 | 2024 | 2040 | 0.350 |
Why?
|
Risk | 9 | 2019 | 9606 | 0.340 |
Why?
|
Skin | 9 | 2023 | 4499 | 0.340 |
Why?
|
Penetrance | 1 | 2011 | 388 | 0.330 |
Why?
|
Receptor, Nerve Growth Factor | 1 | 2009 | 48 | 0.330 |
Why?
|
Inheritance Patterns | 6 | 2020 | 344 | 0.330 |
Why?
|
Jurkat Cells | 3 | 2019 | 740 | 0.320 |
Why?
|
Chemokine CCL5 | 2 | 2000 | 214 | 0.320 |
Why?
|
Genome, Bacterial | 3 | 2024 | 796 | 0.320 |
Why?
|
Anti-Inflammatory Agents | 2 | 2017 | 1804 | 0.310 |
Why?
|
Oligonucleotide Array Sequence Analysis | 9 | 2012 | 3797 | 0.300 |
Why?
|
Chromosomes, Human | 2 | 2018 | 437 | 0.300 |
Why?
|
Receptor, trkA | 1 | 2009 | 159 | 0.300 |
Why?
|
Colitis, Ulcerative | 6 | 2024 | 1924 | 0.290 |
Why?
|
Risk Factors | 38 | 2023 | 74886 | 0.290 |
Why?
|
Models, Molecular | 4 | 2016 | 5388 | 0.290 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 2 | 2020 | 64 | 0.280 |
Why?
|
Base Sequence | 5 | 2020 | 12414 | 0.280 |
Why?
|
Male | 82 | 2024 | 364203 | 0.280 |
Why?
|
Inflammasomes | 1 | 2012 | 540 | 0.270 |
Why?
|
Polymorphism, Genetic | 4 | 2022 | 4247 | 0.270 |
Why?
|
Nervous System Diseases | 2 | 2012 | 1660 | 0.270 |
Why?
|
Methotrexate | 4 | 2024 | 1718 | 0.260 |
Why?
|
Diabetes Mellitus, Type 2 | 10 | 2022 | 12250 | 0.260 |
Why?
|
Drug Discovery | 2 | 2013 | 1068 | 0.260 |
Why?
|
Pharmacogenetics | 1 | 2010 | 682 | 0.260 |
Why?
|
Animals | 29 | 2024 | 168965 | 0.260 |
Why?
|
Antibodies, Monoclonal | 3 | 2014 | 9245 | 0.250 |
Why?
|
CD8-Positive T-Lymphocytes | 6 | 2024 | 4648 | 0.250 |
Why?
|
Multiprotein Complexes | 1 | 2012 | 1110 | 0.250 |
Why?
|
Delivery of Health Care | 2 | 2020 | 5363 | 0.250 |
Why?
|
Spondylitis, Ankylosing | 2 | 2018 | 158 | 0.250 |
Why?
|
Peptides, Cyclic | 7 | 2017 | 390 | 0.250 |
Why?
|
Principal Component Analysis | 4 | 2018 | 950 | 0.240 |
Why?
|
Cell Shape | 2 | 2024 | 372 | 0.240 |
Why?
|
Thioredoxin-Disulfide Reductase | 1 | 2024 | 52 | 0.240 |
Why?
|
DNA Copy Number Variations | 2 | 2010 | 2047 | 0.240 |
Why?
|
Female | 75 | 2024 | 396660 | 0.230 |
Why?
|
RNA, Messenger | 3 | 2018 | 12793 | 0.230 |
Why?
|
Models, Statistical | 3 | 2016 | 5098 | 0.230 |
Why?
|
Opportunistic Infections | 1 | 2007 | 375 | 0.230 |
Why?
|
Regulatory Elements, Transcriptional | 2 | 2015 | 183 | 0.220 |
Why?
|
Natural Language Processing | 3 | 2003 | 1202 | 0.220 |
Why?
|
Depressive Disorder, Major | 3 | 2024 | 4813 | 0.220 |
Why?
|
Amino Acid Sequence | 4 | 2024 | 13411 | 0.220 |
Why?
|
Skin Diseases | 1 | 2012 | 1083 | 0.220 |
Why?
|
Histones | 5 | 2019 | 2597 | 0.220 |
Why?
|
Synovial Fluid | 3 | 2020 | 391 | 0.210 |
Why?
|
Mice | 18 | 2024 | 81912 | 0.210 |
Why?
|
Epistasis, Genetic | 2 | 2015 | 353 | 0.210 |
Why?
|
Joints | 4 | 2019 | 324 | 0.210 |
Why?
|
Telemedicine | 1 | 2020 | 3110 | 0.210 |
Why?
|
Transcription Factor AP-1 | 1 | 2024 | 321 | 0.200 |
Why?
|
Receptors, Glucocorticoid | 1 | 2024 | 309 | 0.200 |
Why?
|
Epigenesis, Genetic | 4 | 2024 | 3828 | 0.200 |
Why?
|
Rheumatoid Factor | 3 | 2024 | 185 | 0.200 |
Why?
|
Open Reading Frames | 2 | 2017 | 818 | 0.200 |
Why?
|
Interleukin-16 | 1 | 2022 | 34 | 0.200 |
Why?
|
Glomerulonephritis, IGA | 1 | 2022 | 61 | 0.200 |
Why?
|
Genetic Diseases, Inborn | 2 | 2019 | 606 | 0.200 |
Why?
|
Mutant Proteins | 1 | 2024 | 487 | 0.190 |
Why?
|
Chemokines, CX3C | 1 | 2001 | 12 | 0.190 |
Why?
|
T-Box Domain Proteins | 1 | 2024 | 471 | 0.190 |
Why?
|
Sequence Alignment | 2 | 2003 | 2176 | 0.190 |
Why?
|
Biopsy | 6 | 2023 | 6777 | 0.190 |
Why?
|
Burkitt Lymphoma | 1 | 2024 | 338 | 0.190 |
Why?
|
Allergy and Immunology | 1 | 2013 | 170 | 0.180 |
Why?
|
Receptors, CCR2 | 1 | 2022 | 215 | 0.180 |
Why?
|
Citrulline | 3 | 2017 | 107 | 0.180 |
Why?
|
Sex Factors | 7 | 2021 | 10622 | 0.180 |
Why?
|
HLA-DQ Antigens | 1 | 2021 | 190 | 0.180 |
Why?
|
Cells, Cultured | 7 | 2020 | 18989 | 0.180 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2021 | 113 | 0.180 |
Why?
|
Signal Transduction | 10 | 2024 | 23621 | 0.180 |
Why?
|
Complement C4 | 1 | 2021 | 216 | 0.180 |
Why?
|
Computer Simulation | 7 | 2022 | 6260 | 0.180 |
Why?
|
Microfibrils | 1 | 2020 | 16 | 0.180 |
Why?
|
Esters | 1 | 2021 | 212 | 0.180 |
Why?
|
Chromosomes | 1 | 2023 | 578 | 0.180 |
Why?
|
Dendritic Cells | 3 | 2024 | 2745 | 0.180 |
Why?
|
Indians, South American | 1 | 2020 | 34 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8736 | 0.180 |
Why?
|
Saccharomyces cerevisiae | 5 | 2003 | 2678 | 0.170 |
Why?
|
Adult | 42 | 2024 | 223317 | 0.170 |
Why?
|
Middle Aged | 41 | 2024 | 223233 | 0.170 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2019 | 3667 | 0.170 |
Why?
|
Chemokine CXCL2 | 1 | 2020 | 105 | 0.170 |
Why?
|
Sulfhydryl Compounds | 1 | 2021 | 296 | 0.170 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2022 | 347 | 0.170 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2017 | 1331 | 0.170 |
Why?
|
Severity of Illness Index | 8 | 2015 | 15925 | 0.170 |
Why?
|
Chemokine CXCL1 | 1 | 2020 | 102 | 0.170 |
Why?
|
Heredity | 1 | 2020 | 149 | 0.170 |
Why?
|
Antigens, CD | 3 | 2019 | 4032 | 0.170 |
Why?
|
Viral Load | 2 | 2021 | 3385 | 0.160 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2020 | 139 | 0.160 |
Why?
|
Peptides | 2 | 2022 | 4348 | 0.160 |
Why?
|
Chemotactic Factors | 1 | 2020 | 197 | 0.160 |
Why?
|
Myositis | 1 | 2022 | 268 | 0.160 |
Why?
|
Nephrotic Syndrome | 1 | 2023 | 381 | 0.160 |
Why?
|
Dermatomyositis | 1 | 2022 | 259 | 0.160 |
Why?
|
Public-Private Sector Partnerships | 1 | 2020 | 123 | 0.160 |
Why?
|
Electronic Health Records | 6 | 2022 | 4881 | 0.160 |
Why?
|
Neutrophil Infiltration | 1 | 2021 | 393 | 0.160 |
Why?
|
Cell Proliferation | 4 | 2021 | 10455 | 0.160 |
Why?
|
Amides | 1 | 2021 | 451 | 0.160 |
Why?
|
Endothelial Cells | 3 | 2022 | 3582 | 0.160 |
Why?
|
Transcription Factor RelA | 1 | 2020 | 252 | 0.160 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2021 | 757 | 0.160 |
Why?
|
Neutrophils | 2 | 2021 | 3779 | 0.160 |
Why?
|
Metabolic Networks and Pathways | 3 | 2012 | 800 | 0.150 |
Why?
|
Pemphigus | 1 | 2019 | 107 | 0.150 |
Why?
|
Neuroimmunomodulation | 1 | 2000 | 186 | 0.150 |
Why?
|
Nerve Growth Factors | 2 | 1999 | 564 | 0.150 |
Why?
|
Foot Joints | 2 | 2015 | 34 | 0.150 |
Why?
|
Mesenchymal Stem Cells | 2 | 2020 | 1665 | 0.150 |
Why?
|
Rheumatic Fever | 2 | 2015 | 73 | 0.150 |
Why?
|
Chemokines, CXC | 1 | 2020 | 420 | 0.150 |
Why?
|
Receptors, IgG | 1 | 2021 | 563 | 0.150 |
Why?
|
Kidney | 4 | 2022 | 7063 | 0.150 |
Why?
|
Hand Joints | 2 | 2015 | 58 | 0.150 |
Why?
|
Reference Standards | 1 | 2021 | 1011 | 0.150 |
Why?
|
Interleukin-1 | 1 | 2021 | 1252 | 0.150 |
Why?
|
Sequence Analysis, DNA | 3 | 2014 | 4780 | 0.150 |
Why?
|
Organ Specificity | 3 | 2017 | 1966 | 0.140 |
Why?
|
Adipocytes | 1 | 2024 | 1197 | 0.140 |
Why?
|
Antigen-Presenting Cells | 1 | 2001 | 960 | 0.140 |
Why?
|
High-Throughput Screening Assays | 3 | 2018 | 940 | 0.140 |
Why?
|
Biotechnology | 1 | 2019 | 282 | 0.140 |
Why?
|
Nasal Polyps | 1 | 2023 | 412 | 0.140 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2024 | 616 | 0.140 |
Why?
|
Lichen Planus | 1 | 1998 | 70 | 0.140 |
Why?
|
Information Storage and Retrieval | 1 | 2003 | 833 | 0.140 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2022 | 3114 | 0.140 |
Why?
|
Chemokines | 2 | 2020 | 963 | 0.140 |
Why?
|
Kidney Tubules | 1 | 2019 | 454 | 0.140 |
Why?
|
Genetic Linkage | 3 | 2013 | 2342 | 0.140 |
Why?
|
Biological Products | 3 | 2022 | 948 | 0.140 |
Why?
|
Chymotrypsin | 1 | 2016 | 136 | 0.140 |
Why?
|
Neurons, Afferent | 2 | 1998 | 498 | 0.140 |
Why?
|
HLA-DR Antigens | 1 | 2018 | 609 | 0.140 |
Why?
|
Amino Acid Oxidoreductases | 1 | 2017 | 149 | 0.140 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5794 | 0.140 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 479 | 0.140 |
Why?
|
Scleroderma, Systemic | 2 | 2018 | 346 | 0.140 |
Why?
|
Logistic Models | 4 | 2017 | 13284 | 0.130 |
Why?
|
Complement Activation | 2 | 2021 | 447 | 0.130 |
Why?
|
Bruch Membrane | 1 | 2016 | 65 | 0.130 |
Why?
|
Hydrocortisone | 1 | 2024 | 1840 | 0.130 |
Why?
|
Cohort Studies | 15 | 2024 | 41718 | 0.130 |
Why?
|
Gases | 1 | 1997 | 205 | 0.130 |
Why?
|
Bipolar Disorder | 3 | 2018 | 5130 | 0.130 |
Why?
|
Apyrase | 1 | 2019 | 376 | 0.130 |
Why?
|
Cholangitis, Sclerosing | 2 | 2016 | 179 | 0.130 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2024 | 976 | 0.130 |
Why?
|
Japan | 5 | 2020 | 1418 | 0.130 |
Why?
|
Exfoliation Syndrome | 1 | 2017 | 113 | 0.130 |
Why?
|
Retinal Drusen | 1 | 2016 | 78 | 0.130 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2016 | 53 | 0.130 |
Why?
|
Protein Binding | 5 | 2021 | 9327 | 0.130 |
Why?
|
Herpes Zoster | 1 | 2018 | 252 | 0.130 |
Why?
|
Mice, Inbred DBA | 1 | 2017 | 624 | 0.130 |
Why?
|
Enzymes | 1 | 1997 | 254 | 0.130 |
Why?
|
CCN Intercellular Signaling Proteins | 1 | 2015 | 24 | 0.130 |
Why?
|
Gene Regulatory Networks | 3 | 2022 | 1752 | 0.130 |
Why?
|
Medical Records | 1 | 2021 | 1409 | 0.120 |
Why?
|
Cell Lineage | 2 | 2022 | 2575 | 0.120 |
Why?
|
Eye Diseases, Hereditary | 1 | 2016 | 124 | 0.120 |
Why?
|
TYK2 Kinase | 1 | 2015 | 38 | 0.120 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2209 | 0.120 |
Why?
|
Finger Joint | 1 | 2015 | 108 | 0.120 |
Why?
|
Interferon Type I | 1 | 2019 | 568 | 0.120 |
Why?
|
Rhinitis | 1 | 2023 | 753 | 0.120 |
Why?
|
Glucocorticoids | 1 | 2024 | 2163 | 0.120 |
Why?
|
Models, Biological | 3 | 2022 | 9464 | 0.120 |
Why?
|
Group II Chaperonins | 1 | 2014 | 7 | 0.120 |
Why?
|
Pericytes | 1 | 2018 | 298 | 0.120 |
Why?
|
Aged | 25 | 2024 | 171319 | 0.120 |
Why?
|
Cell Nucleus | 1 | 2024 | 2875 | 0.120 |
Why?
|
HIV Infections | 1 | 2021 | 17542 | 0.120 |
Why?
|
Research | 2 | 2010 | 1977 | 0.120 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2018 | 1352 | 0.120 |
Why?
|
Neuropeptides | 3 | 2000 | 950 | 0.120 |
Why?
|
Smoking | 4 | 2020 | 9081 | 0.120 |
Why?
|
Genes, MHC Class II | 1 | 2015 | 433 | 0.120 |
Why?
|
Protein Structure, Secondary | 1 | 1997 | 1211 | 0.120 |
Why?
|
Anticholesteremic Agents | 1 | 2021 | 969 | 0.110 |
Why?
|
Interferon Regulatory Factor-7 | 1 | 2014 | 36 | 0.110 |
Why?
|
Leukocytes | 2 | 2019 | 2034 | 0.110 |
Why?
|
DNA, Intergenic | 1 | 2014 | 108 | 0.110 |
Why?
|
Lymphocytes | 2 | 2019 | 2605 | 0.110 |
Why?
|
Lysophospholipase | 1 | 2014 | 66 | 0.110 |
Why?
|
Workflow | 1 | 2019 | 859 | 0.110 |
Why?
|
Gene Dosage | 3 | 2021 | 1211 | 0.110 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1560 | 0.110 |
Why?
|
Epitopes | 3 | 2015 | 2526 | 0.110 |
Why?
|
Cardiomegaly | 1 | 2016 | 591 | 0.110 |
Why?
|
Pedigree | 3 | 2016 | 4539 | 0.110 |
Why?
|
Indians, North American | 1 | 2017 | 354 | 0.110 |
Why?
|
Neoplasm Proteins | 3 | 2017 | 3599 | 0.110 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18330 | 0.110 |
Why?
|
Sinusitis | 1 | 2023 | 997 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1085 | 0.110 |
Why?
|
Mendelian Randomization Analysis | 2 | 2016 | 1040 | 0.110 |
Why?
|
Th1 Cells | 1 | 2018 | 1040 | 0.110 |
Why?
|
Antigens, Neoplasm | 1 | 2021 | 1997 | 0.110 |
Why?
|
STAT Transcription Factors | 1 | 2014 | 189 | 0.110 |
Why?
|
HLA-B8 Antigen | 1 | 2012 | 16 | 0.110 |
Why?
|
Semaphorins | 1 | 2013 | 96 | 0.110 |
Why?
|
Typhoid Fever | 1 | 2014 | 195 | 0.100 |
Why?
|
Models, Theoretical | 5 | 2021 | 3561 | 0.100 |
Why?
|
Colon | 1 | 2021 | 1797 | 0.100 |
Why?
|
Interleukin-23 | 1 | 2014 | 202 | 0.100 |
Why?
|
Skin Diseases, Infectious | 1 | 1993 | 75 | 0.100 |
Why?
|
Osteoporosis | 2 | 2013 | 1604 | 0.100 |
Why?
|
Proteomics | 3 | 2022 | 3913 | 0.100 |
Why?
|
Autistic Disorder | 1 | 2022 | 1239 | 0.100 |
Why?
|
HEK293 Cells | 2 | 2019 | 4280 | 0.100 |
Why?
|
Erythroid Cells | 1 | 2014 | 237 | 0.100 |
Why?
|
Hydrolases | 1 | 2013 | 146 | 0.100 |
Why?
|
Models, Immunological | 1 | 2014 | 516 | 0.100 |
Why?
|
Biomarkers, Pharmacological | 1 | 2013 | 161 | 0.100 |
Why?
|
Lung Diseases, Interstitial | 1 | 2021 | 940 | 0.100 |
Why?
|
Outpatients | 1 | 2020 | 1600 | 0.100 |
Why?
|
Proto-Oncogenes | 1 | 2013 | 321 | 0.100 |
Why?
|
Genes, Recessive | 1 | 2014 | 624 | 0.100 |
Why?
|
Consanguinity | 1 | 2014 | 460 | 0.100 |
Why?
|
Serine Endopeptidases | 2 | 2019 | 1027 | 0.100 |
Why?
|
Point Mutation | 1 | 2017 | 1591 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2016 | 1900 | 0.100 |
Why?
|
Collagen Type X | 1 | 2011 | 16 | 0.100 |
Why?
|
Joint Diseases | 1 | 2015 | 461 | 0.090 |
Why?
|
Drug Hypersensitivity | 1 | 2020 | 903 | 0.090 |
Why?
|
Databases, Nucleic Acid | 1 | 2012 | 203 | 0.090 |
Why?
|
Mice, Inbred C57BL | 3 | 2024 | 22361 | 0.090 |
Why?
|
Liver Cirrhosis, Biliary | 1 | 2012 | 108 | 0.090 |
Why?
|
Fibrinogen | 1 | 2015 | 892 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-rel | 1 | 2011 | 71 | 0.090 |
Why?
|
HIV-1 | 2 | 2021 | 6951 | 0.090 |
Why?
|
Geographic Atrophy | 1 | 2012 | 92 | 0.090 |
Why?
|
Child Development Disorders, Pervasive | 2 | 2013 | 597 | 0.090 |
Why?
|
Complement System Proteins | 1 | 2014 | 738 | 0.090 |
Why?
|
Mycobacterium | 1 | 2012 | 252 | 0.090 |
Why?
|
Age Factors | 2 | 2021 | 18401 | 0.090 |
Why?
|
Stress, Psychological | 4 | 2000 | 4526 | 0.090 |
Why?
|
Proline | 1 | 2012 | 454 | 0.090 |
Why?
|
Peer Review, Research | 1 | 2014 | 343 | 0.090 |
Why?
|
Interleukin-2 | 2 | 2023 | 1894 | 0.090 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3427 | 0.090 |
Why?
|
Loss of Heterozygosity | 1 | 2013 | 663 | 0.090 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2012 | 418 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2019 | 1592 | 0.090 |
Why?
|
Transcription, Genetic | 1 | 2024 | 7611 | 0.090 |
Why?
|
Mice, Knockout | 4 | 2024 | 14476 | 0.090 |
Why?
|
Lipoproteins, LDL | 1 | 2013 | 640 | 0.090 |
Why?
|
Twin Studies as Topic | 1 | 2010 | 103 | 0.080 |
Why?
|
Europe | 4 | 2020 | 3432 | 0.080 |
Why?
|
Alanine | 1 | 2012 | 613 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2020 | 3227 | 0.080 |
Why?
|
Myasthenia Gravis | 1 | 2012 | 214 | 0.080 |
Why?
|
Substance P | 3 | 2000 | 331 | 0.080 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2011 | 165 | 0.080 |
Why?
|
Calcium Signaling | 1 | 2014 | 736 | 0.080 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2012 | 640 | 0.080 |
Why?
|
Metabolic Diseases | 1 | 2016 | 684 | 0.080 |
Why?
|
Long QT Syndrome | 1 | 2014 | 473 | 0.080 |
Why?
|
Child | 11 | 2024 | 80771 | 0.080 |
Why?
|
Computer Graphics | 1 | 2011 | 345 | 0.080 |
Why?
|
Histocompatibility Testing | 2 | 2021 | 717 | 0.080 |
Why?
|
Psychoneuroimmunology | 2 | 2000 | 13 | 0.080 |
Why?
|
Receptor Cross-Talk | 1 | 2009 | 118 | 0.080 |
Why?
|
Heterozygote | 2 | 2015 | 2794 | 0.080 |
Why?
|
Choroidal Neovascularization | 1 | 2012 | 364 | 0.080 |
Why?
|
Collagen | 1 | 2017 | 2636 | 0.080 |
Why?
|
Membrane Proteins | 3 | 2019 | 7868 | 0.080 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2009 | 258 | 0.080 |
Why?
|
Interferons | 2 | 2024 | 716 | 0.080 |
Why?
|
Comorbidity | 2 | 2020 | 10582 | 0.080 |
Why?
|
Mutation | 3 | 2024 | 30211 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2017 | 2028 | 0.070 |
Why?
|
Demography | 1 | 2013 | 1641 | 0.070 |
Why?
|
Immunity, Innate | 4 | 2024 | 3076 | 0.070 |
Why?
|
GTPase-Activating Proteins | 1 | 2011 | 467 | 0.070 |
Why?
|
Osteoporotic Fractures | 1 | 2013 | 417 | 0.070 |
Why?
|
Lipase | 1 | 2010 | 320 | 0.070 |
Why?
|
Bayes Theorem | 2 | 2016 | 2353 | 0.070 |
Why?
|
Interferon Regulatory Factors | 1 | 2009 | 271 | 0.070 |
Why?
|
Young Adult | 9 | 2021 | 59980 | 0.070 |
Why?
|
Data Interpretation, Statistical | 2 | 2015 | 2698 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2021 | 59548 | 0.070 |
Why?
|
Family Health | 1 | 2012 | 1254 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7848 | 0.070 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2011 | 632 | 0.070 |
Why?
|
Prolactin | 1 | 2009 | 627 | 0.070 |
Why?
|
Neoplasms | 4 | 2022 | 22350 | 0.070 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2009 | 897 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2702 | 0.070 |
Why?
|
Brain | 3 | 2024 | 27163 | 0.070 |
Why?
|
Molecular Targeted Therapy | 2 | 2019 | 2824 | 0.070 |
Why?
|
Glioblastoma | 1 | 2022 | 3461 | 0.070 |
Why?
|
Immunoenzyme Techniques | 2 | 2001 | 1697 | 0.070 |
Why?
|
Proteins | 3 | 2012 | 6001 | 0.070 |
Why?
|
Genetics, Medical | 1 | 2009 | 334 | 0.070 |
Why?
|
Immunoglobulin G | 2 | 2015 | 4560 | 0.070 |
Why?
|
Adiponectin | 1 | 2012 | 1115 | 0.060 |
Why?
|
Up-Regulation | 3 | 2001 | 4143 | 0.060 |
Why?
|
Cell Line | 1 | 2020 | 15567 | 0.060 |
Why?
|
Dyslipidemias | 1 | 2013 | 872 | 0.060 |
Why?
|
Body Weight | 2 | 2010 | 4627 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14766 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2013 | 9612 | 0.060 |
Why?
|
11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2024 | 29 | 0.060 |
Why?
|
Neurodegenerative Diseases | 1 | 2014 | 1089 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1965 | 0.060 |
Why?
|
Mental Disorders | 2 | 2016 | 6873 | 0.060 |
Why?
|
Treatment Outcome | 6 | 2019 | 65295 | 0.060 |
Why?
|
Risk Assessment | 4 | 2015 | 24299 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3851 | 0.060 |
Why?
|
Leukocytes, Mononuclear | 2 | 2023 | 1854 | 0.060 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1642 | 0.060 |
Why?
|
Exons | 3 | 2015 | 2391 | 0.060 |
Why?
|
Cell Movement | 3 | 2021 | 5203 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5886 | 0.050 |
Why?
|
Heart Diseases | 1 | 2016 | 2817 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2018 | 11657 | 0.050 |
Why?
|
Interleukin-1beta | 1 | 2009 | 1027 | 0.050 |
Why?
|
Lymphocyte Subsets | 1 | 2024 | 313 | 0.050 |
Why?
|
Autoantigens | 2 | 2017 | 890 | 0.050 |
Why?
|
Antigen Presentation | 2 | 2021 | 1250 | 0.050 |
Why?
|
Odds Ratio | 4 | 2015 | 9660 | 0.050 |
Why?
|
Genes, Insect | 1 | 2003 | 265 | 0.050 |
Why?
|
Discriminant Analysis | 1 | 2002 | 222 | 0.050 |
Why?
|
PubMed | 1 | 2003 | 129 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4424 | 0.050 |
Why?
|
Lung | 1 | 2021 | 10076 | 0.050 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 2015 | 322 | 0.050 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2003 | 1057 | 0.050 |
Why?
|
Adipogenesis | 1 | 2024 | 370 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2011 | 2428 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39317 | 0.050 |
Why?
|
Sialoglycoproteins | 1 | 2003 | 316 | 0.050 |
Why?
|
Extracellular Matrix Proteins | 2 | 2019 | 832 | 0.050 |
Why?
|
Antibiotic Prophylaxis | 1 | 2007 | 640 | 0.050 |
Why?
|
Multiple Sclerosis | 3 | 2014 | 3229 | 0.050 |
Why?
|
Prognosis | 4 | 2019 | 29963 | 0.050 |
Why?
|
Cell Division | 1 | 2009 | 4473 | 0.050 |
Why?
|
Genome, Fungal | 1 | 2002 | 203 | 0.050 |
Why?
|
Registries | 3 | 2015 | 8351 | 0.050 |
Why?
|
Information Services | 1 | 2002 | 239 | 0.050 |
Why?
|
Peptide T | 1 | 2000 | 3 | 0.050 |
Why?
|
Chemokine CX3CL1 | 1 | 2001 | 62 | 0.050 |
Why?
|
Osteoarthritis | 1 | 2009 | 1072 | 0.050 |
Why?
|
Homozygote | 2 | 2018 | 1774 | 0.050 |
Why?
|
Organizations | 1 | 2022 | 172 | 0.050 |
Why?
|
Publications | 1 | 2003 | 195 | 0.050 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2024 | 637 | 0.040 |
Why?
|
Genetic Testing | 1 | 2014 | 3591 | 0.040 |
Why?
|
Plasma Cells | 1 | 2024 | 599 | 0.040 |
Why?
|
Granzymes | 1 | 2022 | 277 | 0.040 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2022 | 341 | 0.040 |
Why?
|
Adolescent | 5 | 2021 | 89046 | 0.040 |
Why?
|
Receptors, Interleukin-1 | 1 | 2021 | 260 | 0.040 |
Why?
|
Interleukin-13 | 1 | 2023 | 391 | 0.040 |
Why?
|
Blood Glucose | 2 | 2012 | 6421 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6550 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 26325 | 0.040 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2002 | 781 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2011 | 3511 | 0.040 |
Why?
|
Fractures, Bone | 1 | 2012 | 2062 | 0.040 |
Why?
|
Injections, Intralesional | 1 | 2000 | 280 | 0.040 |
Why?
|
Spores, Fungal | 1 | 2000 | 89 | 0.040 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2021 | 301 | 0.040 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2000 | 199 | 0.040 |
Why?
|
Age of Onset | 2 | 2012 | 3344 | 0.040 |
Why?
|
Medical Record Linkage | 1 | 2021 | 286 | 0.040 |
Why?
|
Antigen-Antibody Complex | 1 | 2021 | 512 | 0.040 |
Why?
|
Remission, Spontaneous | 1 | 2000 | 384 | 0.040 |
Why?
|
Relaxation Therapy | 1 | 2000 | 181 | 0.040 |
Why?
|
Chromosome Disorders | 1 | 2022 | 498 | 0.040 |
Why?
|
International Cooperation | 2 | 2020 | 1434 | 0.040 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2020 | 370 | 0.040 |
Why?
|
Gelatinases | 1 | 2019 | 93 | 0.040 |
Why?
|
Epithelial Cells | 2 | 2023 | 3698 | 0.040 |
Why?
|
Receptor, Insulin | 1 | 2023 | 839 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2022 | 992 | 0.040 |
Why?
|
Interleukin-4 | 1 | 2023 | 1156 | 0.040 |
Why?
|
Bone Density | 1 | 2012 | 3573 | 0.040 |
Why?
|
Prevalence | 1 | 2016 | 15851 | 0.040 |
Why?
|
Netherlands | 2 | 2015 | 2277 | 0.040 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2024 | 724 | 0.040 |
Why?
|
Obesity | 3 | 2014 | 13085 | 0.040 |
Why?
|
DNA Methylation | 1 | 2013 | 4426 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 8048 | 0.040 |
Why?
|
Transplantation Chimera | 1 | 2001 | 594 | 0.040 |
Why?
|
Calcitonin Gene-Related Peptide | 2 | 1998 | 327 | 0.040 |
Why?
|
Pharyngitis | 1 | 2000 | 221 | 0.040 |
Why?
|
DNA Transposable Elements | 1 | 2002 | 763 | 0.040 |
Why?
|
HLA-B27 Antigen | 1 | 2018 | 66 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2024 | 1079 | 0.040 |
Why?
|
Globulins | 1 | 1997 | 19 | 0.040 |
Why?
|
Fructose-Bisphosphate Aldolase | 1 | 1997 | 43 | 0.040 |
Why?
|
Triose-Phosphate Isomerase | 1 | 1997 | 45 | 0.040 |
Why?
|
Body Mass Index | 2 | 2018 | 13048 | 0.040 |
Why?
|
Alaska | 1 | 2017 | 68 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2021 | 677 | 0.040 |
Why?
|
Systems Biology | 1 | 2021 | 481 | 0.040 |
Why?
|
Regression Analysis | 2 | 2019 | 6331 | 0.040 |
Why?
|
Chromosome Deletion | 1 | 2022 | 1384 | 0.040 |
Why?
|
Macrophage-Activating Factors | 1 | 2017 | 21 | 0.040 |
Why?
|
Ecological Systems, Closed | 1 | 1997 | 3 | 0.040 |
Why?
|
Life Support Systems | 1 | 1997 | 11 | 0.040 |
Why?
|
Penicillins | 1 | 2020 | 404 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2000 | 704 | 0.030 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2021 | 582 | 0.030 |
Why?
|
Excipients | 1 | 1997 | 96 | 0.030 |
Why?
|
Plants, Edible | 1 | 1997 | 29 | 0.030 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 1997 | 109 | 0.030 |
Why?
|
Endocytosis | 1 | 2021 | 951 | 0.030 |
Why?
|
Nitrogen Fixation | 1 | 1997 | 66 | 0.030 |
Why?
|
Chemokine CXCL13 | 1 | 2017 | 62 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10748 | 0.030 |
Why?
|
Static Electricity | 1 | 1997 | 258 | 0.030 |
Why?
|
Receptors, CXCR5 | 1 | 2017 | 88 | 0.030 |
Why?
|
Alcohol Oxidoreductases | 1 | 1997 | 164 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2003 | 3804 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2001 | 2472 | 0.030 |
Why?
|
Racemases and Epimerases | 1 | 1997 | 113 | 0.030 |
Why?
|
Pruritus | 1 | 2000 | 378 | 0.030 |
Why?
|
Vimentin | 1 | 2017 | 257 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 190 | 0.030 |
Why?
|
Collagen Type IV | 1 | 2016 | 125 | 0.030 |
Why?
|
Physical Fitness | 1 | 2000 | 744 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2000 | 11063 | 0.030 |
Why?
|
Kinetics | 2 | 2014 | 6287 | 0.030 |
Why?
|
Mathematics | 1 | 1997 | 696 | 0.030 |
Why?
|
Mice, SCID | 1 | 2001 | 2626 | 0.030 |
Why?
|
Neuropharmacology | 1 | 1995 | 19 | 0.030 |
Why?
|
Cell Polarity | 1 | 2019 | 637 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2015 | 6573 | 0.030 |
Why?
|
Biological Evolution | 1 | 2021 | 1075 | 0.030 |
Why?
|
Pyruvate Kinase | 1 | 1997 | 191 | 0.030 |
Why?
|
Endopeptidases | 1 | 2019 | 762 | 0.030 |
Why?
|
Nitrogen | 1 | 1997 | 344 | 0.030 |
Why?
|
Biphenyl Compounds | 1 | 2000 | 1026 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2017 | 328 | 0.030 |
Why?
|
Receptors, Neurotransmitter | 1 | 1995 | 171 | 0.030 |
Why?
|
Drosophila | 1 | 2003 | 1509 | 0.030 |
Why?
|
Fasting | 2 | 2012 | 1607 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3273 | 0.030 |
Why?
|
Chronic Disease | 2 | 2023 | 9362 | 0.030 |
Why?
|
Neurophysiology | 1 | 1995 | 144 | 0.030 |
Why?
|
Cell Count | 1 | 1999 | 1825 | 0.030 |
Why?
|
Atlases as Topic | 1 | 2016 | 247 | 0.030 |
Why?
|
Chaperonins | 1 | 2014 | 58 | 0.030 |
Why?
|
Skin Physiological Phenomena | 1 | 1995 | 193 | 0.030 |
Why?
|
Normal Distribution | 1 | 2015 | 267 | 0.030 |
Why?
|
Triglycerides | 1 | 2022 | 2444 | 0.030 |
Why?
|
Nerve Fibers | 1 | 1998 | 706 | 0.030 |
Why?
|
Cholesterol, HDL | 2 | 2012 | 1816 | 0.030 |
Why?
|
Aging | 1 | 2013 | 8729 | 0.030 |
Why?
|
Complement C3b | 1 | 2014 | 98 | 0.030 |
Why?
|
Peripheral Nerves | 2 | 1995 | 490 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2018 | 17097 | 0.030 |
Why?
|
Radiography | 2 | 2015 | 6975 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2019 | 837 | 0.030 |
Why?
|
Drosophila melanogaster | 1 | 2003 | 1722 | 0.030 |
Why?
|
Codon, Nonsense | 1 | 2015 | 287 | 0.030 |
Why?
|
Hematinics | 1 | 2017 | 282 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2018 | 2275 | 0.030 |
Why?
|
Pressure | 1 | 1997 | 1172 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12069 | 0.030 |
Why?
|
Vietnam | 1 | 2014 | 413 | 0.030 |
Why?
|
Receptors, Chemokine | 1 | 2017 | 652 | 0.030 |
Why?
|
Lod Score | 1 | 2014 | 600 | 0.030 |
Why?
|
Arginine | 1 | 2017 | 931 | 0.030 |
Why?
|
Nepal | 1 | 2014 | 301 | 0.030 |
Why?
|
Caenorhabditis elegans | 1 | 2003 | 1474 | 0.030 |
Why?
|
Protein Folding | 1 | 1997 | 869 | 0.030 |
Why?
|
Receptors, CCR5 | 1 | 2015 | 491 | 0.030 |
Why?
|
Calcium Channels | 1 | 2017 | 622 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2021 | 2144 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2016 | 11097 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1055 | 0.030 |
Why?
|
Myopathies, Structural, Congenital | 1 | 2014 | 104 | 0.030 |
Why?
|
Finland | 1 | 2014 | 608 | 0.030 |
Why?
|
Cadherins | 1 | 2018 | 903 | 0.030 |
Why?
|
Cryopreservation | 1 | 2018 | 727 | 0.030 |
Why?
|
Eye | 1 | 2017 | 711 | 0.030 |
Why?
|
Particle Size | 1 | 1997 | 1633 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2001 | 2391 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1076 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2003 | 2800 | 0.030 |
Why?
|
Financing, Organized | 1 | 2014 | 202 | 0.030 |
Why?
|
Molecular Chaperones | 1 | 2017 | 760 | 0.030 |
Why?
|
Benchmarking | 1 | 2019 | 1056 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2012 | 14 | 0.030 |
Why?
|
Glycosylation | 1 | 2015 | 1099 | 0.030 |
Why?
|
Complement C3-C5 Convertases, Alternative Pathway | 1 | 2011 | 1 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2014 | 928 | 0.020 |
Why?
|
Leprosy | 1 | 1992 | 125 | 0.020 |
Why?
|
Mycobacterium Infections | 1 | 2012 | 122 | 0.020 |
Why?
|
Exercise | 2 | 2000 | 5954 | 0.020 |
Why?
|
Interferon-beta | 1 | 2014 | 348 | 0.020 |
Why?
|
Lymphoma | 1 | 2001 | 1896 | 0.020 |
Why?
|
Interleukins | 1 | 2017 | 796 | 0.020 |
Why?
|
Fibrosis | 1 | 2019 | 2078 | 0.020 |
Why?
|
Canada | 1 | 2017 | 2127 | 0.020 |
Why?
|
Sample Size | 1 | 2015 | 845 | 0.020 |
Why?
|
Spectrin | 1 | 2012 | 176 | 0.020 |
Why?
|
Republic of Korea | 1 | 2014 | 591 | 0.020 |
Why?
|
Sweden | 1 | 2014 | 1382 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2012 | 162 | 0.020 |
Why?
|
Pakistan | 1 | 2012 | 299 | 0.020 |
Why?
|
Drug Repositioning | 1 | 2013 | 246 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2012 | 654 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2014 | 996 | 0.020 |
Why?
|
Bone Marrow | 1 | 2021 | 2926 | 0.020 |
Why?
|
Foot | 1 | 2015 | 576 | 0.020 |
Why?
|
Lysine | 1 | 2015 | 998 | 0.020 |
Why?
|
Chromosomes, Human, X | 1 | 2013 | 319 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2936 | 0.020 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2012 | 170 | 0.020 |
Why?
|
Waist-Hip Ratio | 1 | 2012 | 520 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2000 | 2270 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2017 | 3093 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2013 | 588 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2015 | 1188 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-3 | 1 | 2010 | 34 | 0.020 |
Why?
|
Cardiovascular Diseases | 2 | 2017 | 15645 | 0.020 |
Why?
|
Ikaros Transcription Factor | 1 | 2012 | 233 | 0.020 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2010 | 71 | 0.020 |
Why?
|
Femur Neck | 1 | 2012 | 318 | 0.020 |
Why?
|
Influenza A virus | 1 | 2014 | 455 | 0.020 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2010 | 103 | 0.020 |
Why?
|
China | 1 | 2016 | 2394 | 0.020 |
Why?
|
Child, Preschool | 3 | 2017 | 42606 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2015 | 1250 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2014 | 20169 | 0.020 |
Why?
|
Antigens, CD19 | 1 | 2013 | 443 | 0.020 |
Why?
|
Italy | 1 | 2012 | 856 | 0.020 |
Why?
|
Folic Acid | 1 | 2017 | 1336 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2021 | 3468 | 0.020 |
Why?
|
Probability | 1 | 2015 | 2476 | 0.020 |
Why?
|
Histocompatibility Antigens | 1 | 2011 | 479 | 0.020 |
Why?
|
Hand | 1 | 2015 | 910 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2850 | 0.020 |
Why?
|
Needs Assessment | 1 | 2015 | 1141 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1733 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2010 | 174 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2014 | 733 | 0.020 |
Why?
|
Neprilysin | 1 | 2012 | 487 | 0.020 |
Why?
|
Life Style | 1 | 2000 | 3931 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2012 | 1181 | 0.020 |
Why?
|
Internet | 1 | 2001 | 3114 | 0.020 |
Why?
|
Germany | 1 | 2011 | 882 | 0.020 |
Why?
|
Self Report | 1 | 2020 | 3773 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1612 | 0.020 |
Why?
|
Arthrography | 1 | 2009 | 149 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8732 | 0.020 |
Why?
|
Bone and Bones | 1 | 2019 | 2587 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 2003 | 2930 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2010 | 412 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1604 | 0.020 |
Why?
|
Siblings | 1 | 2012 | 828 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2015 | 21178 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2002 | 2666 | 0.020 |
Why?
|
Body Size | 1 | 2010 | 462 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2000 | 4045 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2013 | 742 | 0.020 |
Why?
|
Databases, Factual | 2 | 2001 | 8068 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2000 | 2513 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2003 | 4049 | 0.020 |
Why?
|
Population Surveillance | 1 | 2017 | 2594 | 0.020 |
Why?
|
DNA | 1 | 2020 | 7210 | 0.020 |
Why?
|
Multigene Family | 1 | 2010 | 1081 | 0.020 |
Why?
|
Health Status | 2 | 2010 | 4091 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 1997 | 2337 | 0.020 |
Why?
|
Protein Conformation | 1 | 2014 | 3948 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2014 | 2217 | 0.020 |
Why?
|
Death, Sudden, Cardiac | 1 | 2014 | 1567 | 0.020 |
Why?
|
Osteogenesis | 1 | 2013 | 1285 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5875 | 0.020 |
Why?
|
Communicable Diseases | 1 | 2014 | 872 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4745 | 0.020 |
Why?
|
Gene Amplification | 1 | 2010 | 1088 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 1326 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1655 | 0.010 |
Why?
|
NF-kappa B | 1 | 2013 | 2493 | 0.010 |
Why?
|
International Classification of Diseases | 1 | 2010 | 935 | 0.010 |
Why?
|
Glycoproteins | 1 | 2012 | 2200 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 2014 | 2257 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1405 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2012 | 2448 | 0.010 |
Why?
|
Zebrafish | 1 | 2014 | 3036 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2010 | 1829 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4572 | 0.010 |
Why?
|
Range of Motion, Articular | 1 | 2009 | 1597 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2017 | 12451 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15424 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2012 | 1885 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12986 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2014 | 3837 | 0.010 |
Why?
|
Hematologic Neoplasms | 1 | 2013 | 1907 | 0.010 |
Why?
|
Escherichia coli | 1 | 2014 | 4209 | 0.010 |
Why?
|
Ligases | 1 | 2003 | 330 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11217 | 0.010 |
Why?
|
Myocardium | 1 | 2014 | 4765 | 0.010 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2003 | 304 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2003 | 1550 | 0.010 |
Why?
|
Osteopontin | 1 | 2003 | 305 | 0.010 |
Why?
|
Electrocardiography | 1 | 2014 | 6409 | 0.010 |
Why?
|
Databases as Topic | 1 | 2003 | 472 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 1997 | 4422 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5750 | 0.010 |
Why?
|
Parkinson Disease | 1 | 2014 | 2886 | 0.010 |
Why?
|
Lipids | 1 | 2010 | 3322 | 0.010 |
Why?
|
Time Factors | 2 | 2015 | 40154 | 0.010 |
Why?
|
Neurons | 1 | 2018 | 9517 | 0.010 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2013 | 3724 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2012 | 3986 | 0.010 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 1998 | 179 | 0.010 |
Why?
|
Infant | 1 | 2000 | 36485 | 0.010 |
Why?
|
Insulin | 1 | 2012 | 6602 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1998 | 425 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2002 | 1477 | 0.010 |
Why?
|
Tilapia | 1 | 1997 | 24 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2014 | 4713 | 0.010 |
Why?
|
Biomass | 1 | 1997 | 135 | 0.010 |
Why?
|
Entropy | 1 | 1996 | 210 | 0.010 |
Why?
|
Blotting, Western | 1 | 2003 | 5022 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6106 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1997 | 1623 | 0.010 |
Why?
|
Apoptosis | 1 | 2010 | 9513 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 1998 | 1074 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2014 | 8717 | 0.010 |
Why?
|
United States | 1 | 2020 | 72971 | 0.010 |
Why?
|
Oxygen | 1 | 2003 | 4252 | 0.010 |
Why?
|
Recurrence | 1 | 2003 | 8504 | 0.010 |
Why?
|
Periodicals as Topic | 1 | 2001 | 1465 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 17608 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2003 | 12536 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1996 | 3684 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 14672 | 0.000 |
Why?
|